Drug Delivery · 2022 · 16 citations · 66 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyNanomaterialsCancer ImmunotherapyCancer NanomedicineCell-nanoparticle InteractionsInorganic NanoparticlesNanobiomaterialsNanomedicineBiocompatible NanomaterialsCancer NanotherapyImmunosuppressive MicroenvironmentInorganic NanomaterialsNanomaterial ImmunogenicityNanoparticle ImmunogenicityNanoparticle-based ImmunotherapySystemic Immune Response
Cancer has attracted widespread attention from scientists for its high morbidity and mortality, posing great threats to people's health. Cancer immunotherapy with high specificity, low toxicity as well as triggering systemic anti-tumor response has gradually become common in clinical cancer treatment. However, due to the insufficient immunogenicity of tumor antigens peptides, weak ability to precisely target tumor sites, and the formation of tumor immunosuppressive microenvironment, the efficacy of immunotherapy is often limited. In recent years, the emergence of inorganic nanomaterials makes it possible for overcoming the limitations mentioned above. With self-adjuvant properties, high targeting ability, and good biocompatibility, the inorganic nanomaterials have been integrated with cancer immunotherapy and significantly improved the therapeutic effects.
66
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2019 · 21K citations · Full text
A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
Suping Li, Qiao Jiang, Shaoli Liu et al. · Nature Biotechnology · 2018 · 1.5K citations
Cytoplasmic chromatin triggers inflammation in senescence and cancer
Zhixun Dou, Kanad Ghosh, Maria Grazia Vizioli et al. · Nature · 2017 · 1.3K citations · Full text
Near-infrared deep brain stimulation via upconversion nanoparticle–mediated optogenetics
Shuo Chen, Adam Z. Weitemier, Xiao Zeng et al. · Science · 2018 · 1.1K citations · Full text